Neil Hendron Partner

Neil Hendron

Neil works with companies at all stages of development and regularly advises on a wide range of corporate transactions – acting for venture capital and private equity investors, corporates and business owners. The types of transactions Neil delivers range from advising established companies and investors on significant investments to working with spin-out and start-up companies on early stage fundraising rounds.

Private company mergers and acquisition work also represents a material part of Neil's practice and he regularly acts for international corporations and institutional investors on significant acquisitions and divestments and has particular experience in international private company M&A.

Neil helps clients achieve their transactional objectives efficiently and effectively and enjoys helping clients achieve goals that are important to their business. Corporate transactional work can often be complex and Neil sees one of his main roles as trying to manage this complexity and make the process as painless as possible for his clients. An important part of achieving this is working with clients and spending time getting an understanding of their business and what matters most to them.

Highlights

Understanding what makes a business tick, successfully delivering a transaction and having a happy client is the highlight of my job.

Clients

Neil advises a wide range of private equity investors, venture capital funds, corporates and business owners. Examples include: The Montreux Healthcare Fund plc, The Active Care Group, Equiom, Mobeus Equity Partners, Nedbank and NPM Capital. 

Experience

• Acted for Mobeus Equity Partners on the £25.5 million management buy-out of Inbox Insight, a B2B demand generation agency.
• Acting for the consortium of lead investors (including Imperial Innovations, SR One, Pfizer ventures, Roche and Sofinnova) on a £50 million funding round into Mission Therapeutics.
• Acting for the consortium of lead investors (consisting of SR One, SV Life Sciences and Lundbeckfond Invest) on a £16.5 million series A financing of VHSquared Limited.
• Acting for Montreux Capital Management on a series of health care investments and acquisitions in the UK specialist care market.
• Acting for NPM Capital owned Medux on its acquisition of Medequip, a £200 million turnover UK community equipment specialist.
• Acted for the shareholders of Gladman Developments on its £250 million sale to Barratt Developments. 
• Advising Eleven Sports on its acquisitions of MyCujoo and Team Whistle.
• Acting for the shareholders of specialist care provider The Regard Group to AMP Capital.
• Acting for the shareholders of Opus Energy in the sale of Opus Energy to Drax plc for over £340 million.
• Acting global professional services provider Equiom, on its partnership with global alternative investment firm, Värde Partners.
• Acting for Equiom on a series of acquisitions as part of the implementation of its international expansion.
• Acting for Greenko plc on the sale of Greenko Mauritius for $250 million.
• Acting for AstraZeneca on the sale of Carpelsa to Genzyme for up to $300 million.
• Acting for Prostrakan on the acquisition of Archimedes Pharma Limited (European-based specialty pharmaceutical company) for £230 million.
• Acting for Star Capital Partners on its acquisition of Synergy Health Management Services for £50 million.
• Acting for US-listed Dover Corporation on a number of its UK acquisitions.